<?xml version="1.0"?>
<Articles JournalTitle="Immunology and Genetics Journal">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>6</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>03</Month>
        <Day>22</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of ABCB1 Gene Promoter Methylation in Patients with Ulcerative Colitis</title>
    <FirstPage>21</FirstPage>
    <LastPage>27</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Sanjari Moghaddam</LastName>
        <affiliation locale="en_US">School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Golshid</FirstName>
        <LastName>Sanati</LastName>
        <affiliation locale="en_US">Duke Center for Genomic and Computational Biology, Duke University School of Medicine, Durham, NC 27710, USA</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Sadr</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Bahareh</FirstName>
        <LastName>Mohebbi</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahsa</FirstName>
        <LastName>Keshavarz-Fathi</LastName>
        <affiliation locale="en_US">School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Roham</FirstName>
        <LastName>Salmanroghani</LastName>
        <affiliation locale="en_US">Shahid Sadoughi Hospital, Yazd University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Salmanroghani</LastName>
        <affiliation locale="en_US">Shahid Sadoughi Hospital, Yazd University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>09</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The pathogenesis of inflammatory bowel disease may be associated with the disruption in
interactions between the immune system and gut flora. Epigenetic mechanisms especially, DNAmethylation
appear to be significant regarding the interaction between the environment and genome. ABCB1 is the
encoding gene for multi-drug resistance protein 1 (MDR1) (P-glycoprotein), which is an important
transmembrane protein responsible for the efflux of cellular molecules from the intestinal wall to the lumen.
&#xD;


Method: In this study, we compared the methylation status of the promoter of ABCB1 in rectal mucosa of
patients with ulcerative colitis (UC) and healthy controls by using the bisulfite conversion system and real-
time quantitative multiplex methylation-specific PCR (QM-MSP).
&#xD;


Results: We demonstrated that the mucosal specimen of 26 UC patients had significantly higher levels of
promoter methylation in comparison to 26 controls.
&#xD;


Conclusion: As the first investigation of Iranian patients with UC, we showed that patients had higher levels
of ABCB1 promoter methylation in their inflammatory rectal mucosa compared to controls. However, this
altered state of methylation did not associate with the characteristics of the patients such as age and sex. Our
findings are a basis for further studies on concurrent assessment of promoter methylation and expression
of ABCB1 in UC.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/103</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/103/118</pdf_url>
  </Article>
</Articles>
